Better evidence about screening for lung cancer

New England Journal of Medicine

Volumn 365, Issue 5, 2011, Pages 455-457

  Sox, Harold C ^a  

^a DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER PATIENT; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; EDITORIAL; HEALTH CARE POLICY; HUMAN; LUNG CANCER; MEDICAL PRACTICE; PRIORITY JOURNAL; THORAX RADIOGRAPHY;

EID: 79961122250     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe1103776     Document Type: Editorial

References (6)

1. The National Lung Screening Trial Research Team. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med 2011;365:395-409.
2. Idem. Baseline characteristics of participants in the randomized National Lung Screening Trial. J Natl Cancer Inst 2010;102:1771-9.
3. Welch HG, Black WC. Overdiagnosis in cancer. J Natl Cancer Inst 2010;102:605-13.
4. Gauthier ML, Berman HK, Miller C, et al. Abrogated response to cellular stress identifies DCIS associated with subsequent tumor events and defines basal-like breast tumors. Cancer Cell 2007;12:479-91. (Pubitemid 350046408)
5. Kerlikowske K, Molinaro AM, Gauthier ML, et al. Biomarker expression and risk of subsequent tumors after initial ductal carcinoma in situ diagnosis. J Natl Cancer Inst 2010;102:27-37.
6. Marcus PM, Bergstrahl EJ, Zweig MH, Harris A, Offord KP, Fontana RS. Extended lung cancer incidence follow-up in the Mayo Lung Project and overdiagnosis. J Natl Cancer Inst 2006;98:748-56. (Pubitemid 43983298)